BioNexus Gene Lab Corp Common stock (BGLC) had the highest return between 2012 and 2022 by a US stock, returning 2,780,387.8%.

ASSET	YEARS	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2012-2022	2,780,387.8%
KULR Technology (KULR)	2012-2022	2,399,900%
QXO (QXO)	2012-2022	1,338,564.29%
Next Technology (NXTT)	2012-2022	1,162,346.87%
INVO Fertility (IVF)	2012-2022	693,718.18%
Diversified Energy (DEC)	2012-2022	568,050%
Connexa Sports Technologies (YYAI)	2012-2022	467,900%
MDxHealth SA ADR (MDXH)	2012-2022	275,316.67%
Heart Test Laboratories Inc Common Stock (HSCS)	2012-2022	246,958.82%
Helport AI Limited Ordinary Shares (HPAI)	2012-2022	224,566.67%
AquaBounty Technologies (AQB)	2012-2022	212,122.22%
GeoVax Labs (GOVX)	2012-2022	205,334.78%
Immatics (IMTX)	2012-2022	174,100%
Eastside Distilling (BLNE)	2012-2022	137,437.54%
Integra Resources (ITRG)	2012-2022	126,500%
Aurora Cannabis (ACB)	2012-2022	122,966.67%
GT Biopharma (GTBP)	2012-2022	106,220%
Blackboxstocks (BLBX)	2012-2022	70,488.24%
Xpel (XPEL)	2012-2022	66,633.33%
Celsius (CELH)	2012-2022	49,442.86%
Guardforce AI (GFAI)	2012-2022	24,323.08%
FingerMotion (FNGR)	2012-2022	22,380%
Applied Digital (APLD)	2012-2022	18,300%
Cementos Pacasmayo SAA ADR (CPAC)	2012-2022	13,000.67%
LM Funding America (LMFA)	2012-2022	11,051.52%